These findings consistently indicate that homozygosity for the RNF213 p.R4810K variant confers a markedly more severe and early-onset form of MMD, while heterozygosity is generally associated with later onset and milder clinical course [72]. The gene discussed is RNF213; the disease is multiminicore myopathy.